Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
DBMD Disease Information


Candidiasis

Navigation bar

 
 
Clinical Features Oropharyngeal infection (OPC): white mucosal patches. Vulvovaginal infection (VVC): pruritus, vulval erythema, with or without discharge. Systemic infection usually presents as fever and chills unresponsive to antibacterial therapy. May manifest as renal or hepatosplenic infection, meningitis, endophthalmitis, endocarditis, osteomyelitis and/or arthritis.
Etiologic Agent Candida albicans and C. glabrata. Less commonly, C.tropicalis, C. parapsilosis, and C. krusei. Rarely, other Candida species.
Reservoir Forms part of the normal microbial flora of the mouth and gastrointestinal tract.
Incidence Fourth most common cause of nosocomial bloodstream infections. Incidence is 8 cases per 100,000 in the general population. Higher incidence among neonates and African-Americans. OPC used to be a common opportunistic infection in HIV-infected persons (prior to the introduction of highly active antiretroviral therapy [HAART]).
Sequelae None with appropriate antifungal therapy. Mortality rate is almost 50% with bloodstream and disseminated infection.
Transmission Most infections are endogenous in origin, but organisms can be transmitted on the hands of care givers.
Risk Groups Invasive disease occurs in critically ill patients in intensive-care units, in persons with severe granulocytopenia, and in hematopoietic stem cell and organ transplant recipients. OPC can be associated with HIV infection. VVC is often associated with pregnancy, diabetes mellitus, and antibiotic therapy.
Surveillance Nosocomial disease surveillance is conducted by NNIS in selected hospitals. Active population-based surveillance for candidemia is being conducted in selected U.S. sites.
Challenges Identifying modifiable risk factors for disease in immunocompromised and debilitated persons. Developing sensitive and specific methods for earlier diagnosis.
Opportunities Development of rapid antigenemia and antigenuria tests and molecular probes may facilitate earlier clinical diagnosis. Availability of molecular typing methods may assist in epidemiologic studies.

December 2003

 
 
 
   
         

 

CDC Home | Search | Health Topics A-Z

 

This page last reviewed March 08, 2001

Centers for Disease Control and Prevention
National Center for Infectious Diseases
Division of Bacterial and Mycotic Diseases
 
Return to DBMD disease listing go to Additional Information go to General Information